chartexchange

VRAX
Virax Biolabs Group Limited
stockNASDAQ

Market OpenOct 5, 2026 11:55:50 AM EDT
2.34USD+6.364%(+0.14)2,254,971
2.3400Bid2.3600Ask0.0200Spread
Pre-marketOct 5, 2026 9:28:30 AM EDT
2.50USD+13.636%(+0.30)
Loading…
Loading…
Healthcare
Biotechnology
HQ
London, United Kingdom
Previous Close
$2.20
Beta
2.10
52-Week High
$21.75 2025-12-03
52-Week Low
$2.04 2026-09-29
SMA 50
$2.73
SMA 200
$4.67
Avg. Vol 10D
34,324
Avg. Vol 30D
41,509
Avg. Vol 90D
1.29M
Relative Vol
38.64
796,988
19.57M
2455.01%
137.4600%
803
Jun 26, 2026 · 1-for-25 (reverse)
VRAX Performance
PeriodPriceDateChangeBeta
1W2.312026-09-28+1.32%1.510
1M2.632026-09-04-10.67%-2.343
3M3.112026-07-06-24.60%2.331
6M3.822026-04-06-38.61%0.984
1Y15.722025-10-06-85.08%2.102
2Y48.502024-10-04-95.17%—
5Y4,550.002022-07-21-99.95%0.904
VRAX Stock Summary

Virax Biolabs Group Limited (NASDAQ:VRAX) stock price today is $2.35, and today's volume is 1,603,835. VRAX is up 6.591% today. The 30 day average volume is 41,509. VRAX market cap is $1.87M with 796,988 shares outstanding.